Abiraterone Acetate
- Product NDC
- 42292-057
- 11-digit product format
- 422920057
- Labeler code
- 42292
- Product ID
- 42292-057_d3aef164-ffc6-d7a6-e053-2a95a90a5711
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- abiraterone acetate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Institutional Inc.
- Application
- ANDA208446
- Marketing category
- ANDA
- Marketing start
- 2020-06-03
- Marketing end
- 2022-02-28
- Substance
- ABIRATERONE ACETATE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42292-057-03 | 42292005703 | 30 BLISTER PACK in 1 CARTON (42292-057-03) > 1 TABLET in 1 BLISTER PACK (42292-057-01) | 30 blister pack | 2020-06-03 | 0000-00-00 | No | No | Current |